ACCESS 2 IMMUNOASSAY SYSTEM
Report
- Report Number
- 2122870-2010-00441
- Date Received
- August 13, 2010
- Date of Event
- July 15, 2010
- Report Date
- August 13, 2010
- Manufacturer
- BECKMAN COULTER INC.
- Product Code
- JJE
- PMA / PMN Number
- 922823/A007
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER
Narratives
THE SAMPLES ARE LI HEPARIN PLASMA, WHICH WERE CENTRIFUGED FOR 5 MINUTES IN THE STAT SPIN. QC IS ANALYZED ONCE PER DAY AND WAS WITHIN THE CUSTOMERS ESTABLISHED RANGES DURING THE EVENT. ON (B)(4) 2010 THE CUSTOMER PERFORMED SYSTEM CHECK AND IT WAS WITHIN INSTRUMENT SPECIFICATIONS. A BCI FIELD SERVICE ENGINEER (FSE) PERFORMED DIAGNOSTIC SYSTEM CHECK. THE WASHED PORTION FAILED. THE FSE ALSO PERFORMED PM AND DIAGNOSTIC TEST, WHICH PARTIALLY FAILED. FSE REPLACED THE PERI PUMP TUBING, MADE ADJUSTMENT, AND REPEATED THE DIAGNOSTIC TEST, WHICH MET SPECIFICATIONS. ALTHOUGH HARDWARE ISSUES WERE ADDRESSED, A CLEAR ROOT CAUSE CAN NOT BE DETERMINED FOR THIS EVENT.
A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) IN REGARDS TO ERRONEOUSLY ELEVATED ACCUTNI RESULTS FOR TWO PATIENTS ABOVE THE ACUTE MYOCARDIAL INFARCTION (AMI) CUT-OFF GENERATED BY THE ACCESS 2 IMMUNOASSAY ANALYZER. IN ADDITION, A THIRD PATIENT SAMPLE RESULTED IN THE RISK STRATIFICATION RANGE. THE RESULT FOR PATIENT NUMBER TWO WAS REPORTED OUT OF THE LABORATORY. FOR PATIENTS 1 AND 3, A SECONDARY SAMPLE WAS RUN ON THE SAME UNIT AND THE RESULTS WERE WITHIN THE NORMAL REFERENCE RANGE. FOR PATIENT #2 THE SAMPLE WAS REPEATED ON ANOTHER UNIT AND THE RESULT WAS WITHIN THE NORMAL REFERENCE RANGE. AMENDED REPORT WAS INITIATED. NO REPORTS OF DEATH, INJURY, OR CHANGE TO PATIENT TREATMENT HAVE BEEN REPORTED IN CONNECTION WITH THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ACCESS 2 IMMUNOASSAY SYSTEM | DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER | JJE | BECKMAN COULTER INC. | N/A | N/A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |